Literature DB >> 8496691

Presentation of numerous viral peptides to mouse major histocompatibility complex (MHC) class I-restricted T lymphocytes is mediated by the human MHC-encoded transporter or by a hybrid mouse-human transporter.

J W Yewdell1, F Esquivel, D Arnold, T Spies, L C Eisenlohr, J R Bennink.   

Abstract

The major histocompatibility complex-encoded transporter associated with antigen processing (TAP) is required for the efficient presentation of cytosolic antigens to class I-restricted T cells. TAP is thought to be formed by the interaction of two gene products, termed TAP1 and TAP2. We find that TAPs consisting either of human subunits, or mouse TAP1 and human TAP2, facilitate the presentation of numerous defined viral peptides to mouse class I-restricted T cells. As human and mouse TAP2 and TAP1 differ in 23 and 28% of their residues, respectively, this indicates that TAP1 and TAP2 can form a functional complex with partners considerably different from those they coevolved with. Moreover, these findings indicate that widely disparate TAPs facilitate delivery of the same peptides to class I molecules. These findings suggest that TAP polymorphism does not greatly influence the types of peptides presented to the immune system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8496691      PMCID: PMC2191053          DOI: 10.1084/jem.177.6.1785

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  39 in total

1.  Cytotoxic T lymphocytes recognize influenza haemagglutinin that lacks a signal sequence.

Authors:  A R Townsend; J Bastin; K Gould; G G Brownlee
Journal:  Nature       Date:  1986 Dec 11-17       Impact factor: 49.962

2.  Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens.

Authors:  R DeMars; R Rudersdorf; C Chang; J Petersen; J Strandtmann; N Korn; B Sidwell; H T Orr
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

3.  Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses.

Authors:  G L Smith; J Z Levin; P Palese; B Moss
Journal:  Virology       Date:  1987-10       Impact factor: 3.616

4.  Recognition of vaccinia virus-encoded major histocompatibility complex class I antigens by virus immune cytotoxic T cells is independent of the polymorphism of the peptide transporters.

Authors:  M Lobigs; A Müllbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

5.  Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes.

Authors:  J W Yewdell; J R Bennink; G L Smith; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

6.  T cell recognition of QA-1b antigens on cells lacking a functional Tap-2 transporter.

Authors:  C J Aldrich; R Waltrip; E Hermel; M Attaya; K F Lindahl; J J Monaco; J Forman
Journal:  J Immunol       Date:  1992-12-15       Impact factor: 5.422

7.  Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells.

Authors:  J R Bennink; J W Yewdell; G L Smith; C Moller; B Moss
Journal:  Nature       Date:  1984 Oct 11-17       Impact factor: 49.962

8.  Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.

Authors:  S Chakrabarti; K Brechling; B Moss
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

9.  Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid.

Authors:  R D Salter; P Cresswell
Journal:  EMBO J       Date:  1986-05       Impact factor: 11.598

10.  Murine cytotoxic T lymphocyte recognition of individual influenza virus proteins. High frequency of nonresponder MHC class I alleles.

Authors:  J R Bennink; J W Yewdell
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  8 in total

1.  Identification of new TAP2 alleles in gorilla: evolution of the locus within hominoids.

Authors:  P T Loflin; P R Laud; D I Watkins; D A Lawlor
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

Review 2.  Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation.

Authors:  Y Yang; P Sempé; P A Peterson
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

3.  Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner.

Authors:  M J Androlewicz; K S Anderson; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

4.  An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope.

Authors:  T M Fu; L M Mylin; T D Schell; I Bacik; G Russ; J W Yewdell; J R Bennink; S S Tevethia
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

5.  LMP-associated proteolytic activities and TAP-dependent peptide transport for class 1 MHC molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12.

Authors:  R Rotem-Yehudar; M Groettrup; A Soza; P M Kloetzel; R Ehrlich
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

6.  Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen.

Authors:  L M Mylin; R H Bonneau; J D Lippolis; S S Tevethia
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Polymorphic peptide transporters in MHC class I monomorphic Syrian hamster.

Authors:  M Lobigs; H S Rothenfluh; R V Blanden; A Müllbacher
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

8.  Characterization and allelic variation of the transporters associated with antigen processing (TAP) genes in the domestic dog (Canis lupus familiaris).

Authors:  Gregory S Gojanovich; Peter Ross; Savannah G Holmer; Jennifer C Holmes; Paul R Hess
Journal:  Dev Comp Immunol       Date:  2013-07-25       Impact factor: 3.636

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.